These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 14598883

  • 1. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
    Lee KH, Hyun MS, Kim JR.
    Clin Exp Metastasis; 2003; 20(6):499-505. PubMed ID: 14598883
    [Abstract] [Full Text] [Related]

  • 2. Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.
    Lee KH, Choi EY, Kim MK, Hyun MS, Jang BI, Kim TN, Kim SW, Song SK, Kim JH, Kim JR.
    Exp Mol Med; 2006 Feb 28; 38(1):27-35. PubMed ID: 16520550
    [Abstract] [Full Text] [Related]

  • 3. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ, Park IC, Hur JH, Kim MS, Lee HC, Woo SH, Lee KH, Rhee CH, Hong SI, Lee SH.
    J Neurosurg; 2002 Jul 28; 97(1):112-8. PubMed ID: 12134900
    [Abstract] [Full Text] [Related]

  • 4. MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1.
    Ding XZ, Adrian TE.
    Biochem Biophys Res Commun; 2001 Mar 30; 282(2):447-53. PubMed ID: 11401480
    [Abstract] [Full Text] [Related]

  • 5. An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.
    Denkert C, Siegert A, Leclere A, Turzynski A, Hauptmann S.
    Clin Exp Metastasis; 2002 Mar 30; 19(1):79-85. PubMed ID: 11918086
    [Abstract] [Full Text] [Related]

  • 6. Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer.
    Lee KH, Kim JR.
    Oncol Res; 2009 Mar 30; 18(2-3):107-16. PubMed ID: 20066900
    [Abstract] [Full Text] [Related]

  • 7. PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma cells.
    Chattopadhyay N, Tfelt-Hansen J, Brown EM.
    Brain Res Mol Brain Res; 2002 Jun 15; 102(1-2):73-82. PubMed ID: 12191496
    [Abstract] [Full Text] [Related]

  • 8. Cellular mechanisms of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MAPK signaling in hepatocellular carcinoma.
    Lee KH, Choi EY, Hyun MS, Eun JR, Jang BI, Kim TN, Lee HJ, Lee DS, Yun SS, Kim HJ, Kim JH, Kim JR.
    Tumori; 2008 Jun 15; 94(4):523-30. PubMed ID: 18822689
    [Abstract] [Full Text] [Related]

  • 9. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
    Leonard M, Ryan MP, Watson AJ, Schramek H, Healy E.
    Kidney Int; 1999 Oct 15; 56(4):1366-77. PubMed ID: 10504489
    [Abstract] [Full Text] [Related]

  • 10. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM, Roztocil E, Davies MG.
    J Vasc Surg; 2005 Apr 15; 41(4):672-81. PubMed ID: 15874933
    [Abstract] [Full Text] [Related]

  • 11. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.
    Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M, Ishikawa H, Hamasaki K, Nakata K, Eguchi K.
    Hepatology; 2002 May 15; 35(5):1117-24. PubMed ID: 11981761
    [Abstract] [Full Text] [Related]

  • 12. Interferon-gamma inhibits hepatocyte growth factor-stimulated cell proliferation of human bronchial epithelial cells: upregulation of p27(kip1) cyclin-dependent kinase inhibitor.
    Takami K, Takuwa N, Okazaki H, Kobayashi M, Ohtoshi T, Kawasaki S, Dohi M, Yamamoto K, Nakamura T, Tanaka M, Nakahara K, Takuwa Y, Takizawa H.
    Am J Respir Cell Mol Biol; 2002 Feb 15; 26(2):231-8. PubMed ID: 11804875
    [Abstract] [Full Text] [Related]

  • 13. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
    Han YC, Zeng XX, Wang R, Zhao Y, Li BL, Song M.
    Ai Zheng; 2007 Jan 15; 26(1):48-53. PubMed ID: 17222367
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O, Cantley LC.
    Exp Cell Res; 2004 Jul 01; 297(1):224-34. PubMed ID: 15194438
    [Abstract] [Full Text] [Related]

  • 15. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
    Qian LW, Mizumoto K, Inadome N, Nagai E, Sato N, Matsumoto K, Nakamura T, Tanaka M.
    Int J Cancer; 2003 May 01; 104(5):542-9. PubMed ID: 12594808
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; the involvement of ERK, p38 and STAT5.
    Birkenkamp KU, Esselink MT, Kruijer W, Vellenga E.
    Eur Cytokine Netw; 1999 Dec 01; 10(4):479-90. PubMed ID: 10586114
    [Abstract] [Full Text] [Related]

  • 17. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells.
    Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Matsumoto K, Nakamura T, Kaneda Y, Horiuchi M, Ogihara T.
    Hypertension; 2001 Feb 01; 37(2 Pt 2):581-6. PubMed ID: 11230338
    [Abstract] [Full Text] [Related]

  • 18. Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporine A-induced increase in transepithelial resistance.
    Kiely B, Feldman G, Ryan MP.
    Kidney Int; 2003 Mar 01; 63(3):908-16. PubMed ID: 12631071
    [Abstract] [Full Text] [Related]

  • 19. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H, Bulbule A, Kundu GC.
    J Biol Chem; 2004 Sep 10; 279(37):38921-35. PubMed ID: 15247285
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.
    Simon C, Goepfert H, Boyd D.
    Cancer Res; 1998 Mar 15; 58(6):1135-9. PubMed ID: 9515796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.